Dong Hu Selected Research

Etoposide (VP 16)

6/2019	miR-374a Inhibitor Enhances Etoposide-Induced Cytotoxicity Against Glioma Cells Through Upregulation of FOXO1.
8/2015	High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong Hu Research Topics

Disease

38	Neoplasms (Cancer) 04/2024 - 05/2004
12	Inflammation (Inflammations) 01/2024 - 04/2010
10	Fibrosis (Cirrhosis) 12/2023 - 01/2018
9	Infections 01/2023 - 05/2010
8	Breast Neoplasms (Breast Cancer) 03/2022 - 03/2008
6	Tuberculosis (Tuberculoses) 05/2015 - 01/2012
5	Neoplasm Metastasis (Metastasis) 04/2024 - 11/2017
5	Lung Neoplasms (Lung Cancer) 04/2024 - 03/2008
5	Adenocarcinoma of Lung 01/2024 - 01/2021
5	Silicosis 01/2024 - 12/2021
4	Glioma (Gliomas) 02/2020 - 01/2018
4	Carcinogenesis 11/2019 - 04/2012
4	Thrombocytopenia (Thrombopenia) 01/2017 - 06/2014
4	Crohn Disease (Crohn's Disease) 12/2016 - 02/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2020
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2024 - 01/2022
3	Heart Failure 06/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 10/2016 - 03/2008
3	Sepsis (Septicemia) 05/2015 - 01/2013
3	Shock 03/2008 - 07/2004
2	Triple Negative Breast Neoplasms 03/2022 - 06/2019
2	COVID-19 01/2022 - 01/2021
2	Pneumonia (Pneumonitis) 01/2022 - 03/2014
2	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 12/2019
2	Necrosis 01/2022 - 12/2017
2	Fatty Liver 12/2021 - 01/2017
2	Fever (Fevers) 01/2021 - 12/2016
2	Ankylosing Spondylitis 09/2020 - 05/2020
2	Carcinoma (Carcinomatosis) 12/2019 - 01/2018
2	Cryptorchidism (Undescended Testes) 12/2019 - 01/2019
2	Leukemia 11/2019 - 10/2004
2	Osteoarthritis 01/2017 - 01/2017
2	Abdominal Abscess 12/2016 - 08/2015
2	Colonic Neoplasms (Colon Cancer) 10/2016 - 03/2008
2	Starvation 06/2016 - 10/2012
2	Fistula 09/2014 - 03/2014
2	Clonorchiasis 06/2014 - 04/2012
2	Liver Neoplasms (Liver Cancer) 04/2012 - 05/2004
2	Prostatic Neoplasms (Prostate Cancer) 03/2012 - 03/2011
2	Asthma (Bronchial Asthma) 04/2010 - 04/2007
1	Malaria 01/2024
1	Hematologic Neoplasms (Hematological Malignancy) 01/2024
1	Cytokine Release Syndrome 01/2024

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2008
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2018
6	VaccinesIBA 05/2015 - 01/2012
5	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022 - 04/2012
4	AntigensIBA 01/2022 - 05/2004
4	CytokinesIBA 12/2019 - 04/2010
4	beta CateninIBA 08/2009 - 03/2008
3	celastrolIBA 01/2024 - 11/2023
3	CollagenIBA 12/2023 - 01/2022
3	LipidsIBA 12/2021 - 04/2012
3	Conditioned Culture MediaIBA 01/2020 - 01/2018
3	Long Noncoding RNAIBA 01/2020 - 01/2018
3	Protein Kinases (Protein Kinase)IBA 01/2019 - 03/2011
3	DNA VaccinesIBA 12/2014 - 01/2012
3	Immunoglobulin G (IgG)IBA 12/2014 - 05/2010
2	Adenosine (Adenocard)FDA LinkGeneric 01/2024 - 09/2023
2	RNA (Ribonucleic Acid)IBA 01/2024 - 02/2020
2	Neuraminidase (Sialidase)IBA 06/2022 - 01/2022
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2022 - 12/2019
2	Thrombin FDA Link 03/2022 - 12/2019
2	Angiotensin IIIBA 03/2022 - 01/2018
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2022 - 11/2021
2	Vitamin D FDA LinkGeneric 01/2022 - 10/2016
2	Coal (Coals)IBA 01/2022 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2020
2	Coloring Agents (Dyes)IBA 12/2021 - 09/2015
2	NitrogenIBA 01/2021 - 01/2013
2	LipopolysaccharidesIBA 07/2020 - 04/2010
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2020 - 10/2016
2	Etoposide (VP 16)FDA LinkGeneric 06/2019 - 08/2015
2	Messenger RNA (mRNA)IBA 01/2019 - 10/2004
2	Phenobarbital (Luminal)FDA Link 01/2018 - 10/2014
2	WortmanninIBA 06/2016 - 10/2012
2	Thrombopoietin (c-mpl Ligand)IBA 05/2015 - 06/2014
2	Interleukin-2 (IL2)IBA 12/2014 - 04/2014
2	DNA (Deoxyribonucleic Acid)IBA 12/2014 - 04/2014
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2014 - 10/2012
1	Calcium-Binding ProteinsIBA 04/2024
1	cabotegravirIBA 02/2024
1	palbociclibIBA 01/2024
1	PyrazinesIBA 01/2024
1	quinolineIBA 01/2024
1	Mefloquine (Lariam)FDA LinkGeneric 01/2024
1	Chimeric Antigen ReceptorsIBA 01/2024
1	VER 155008IBA 12/2023
1	tetramethylpyrazineIBA 11/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023
1	Caspase 3 (Caspase-3)IBA 11/2023
1	PeroxiredoxinsIBA 11/2023

Therapy/Procedure

16	Therapeutics 01/2024 - 05/2004
5	Immunotherapy 03/2024 - 01/2023
3	Drug Therapy (Chemotherapy) 01/2022 - 06/2019
2	Subcutaneous Injections 04/2024 - 05/2004
2	Critical Care (Surgical Intensive Care) 01/2017 - 03/2014
2	Platelet Transfusion (Blood Platelet Transfusions) 08/2015 - 06/2014
2	Optical Fibers 03/2008 - 07/2004
1	Complementary Therapies (Alternative Medicine) 01/2024